It was recently shown that depletion of SMC5/6 components in human cancer cells (HCT116) or hTERT immortalized non-cancer cells (RPE1) caused activation of CHEK2 and stabilization of p53 (Venegas et al., 2020). This evidence concerns the gene TP53 and cancer.